Wednesday, July 20, 2016

BRIEF-Chugai and Galderma announce global license agreement for Nemolizumab

* Chugai will continue to be responsible for product

manufacturing and supply of Nemolizumab.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)